Sunday, September 13, 2026

Halozyme Therapeutics, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

January 6, 2021

Halozyme Therapeutics, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Green Dot Corporation

5.3% sales growth and 5.05% return on equity

Green Dot Corporation operates as a financial technology and bank holding company in the United States.

Green Dot Corporation's sales growth this year is anticipated to be 12.5% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 1.22B for the twelve trailing months.

Green Dot Corporation's sales growth for the next quarter is 5.3%. The company's growth estimates for the current quarter and the next is 28.6% and negative -3.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.05%.

Volatility

Green Dot Corporation's last day, last week, and last month's average volatility was a negative 2.86%, a negative 1.46%, and a negative 0.26%, respectively.

Green Dot Corporation's last day, last week, and last month's high and low average amplitude percentage was 5.51%, 4.01%, and 4.37%, respectively.

Green Dot Corporation's Stock Yearly Top and Bottom Value

Green Dot Corporation's stock is valued at $53.19 at 19:22 EST, way under its 52-week high of $64.97 and way above its 52-week low of $14.20.

Green Dot Corporation's Moving Average

Green Dot Corporation's worth is below its 50-day moving average of $55.45 and higher than its 200-day moving average of $52.93.

2. Halozyme Therapeutics, Inc.

281.6% sales growth and 12.5% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally.

Halozyme Therapeutics, Inc.'s sales growth this year is expected to be 35.4% and 52.2% for next year.

Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 199.56M for the twelve trailing months.

Halozyme Therapeutics, Inc.'s sales growth for the next quarter is 281.6%. The company's growth estimates for the current quarter and the next is 316.7% and 1025%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.5%.

Volatility

Halozyme Therapeutics, Inc.'s last day, last week, and last month's average volatility was 0.28%, 0.03%, and 0.24%, respectively.

Halozyme Therapeutics, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.74%, 3.08%, and 3.96%, respectively.

Halozyme Therapeutics, Inc.'s Stock Yearly Top and Bottom Value

Halozyme Therapeutics, Inc.'s stock is valued at $42.71 at 19:22 EST, under its 52-week high of $44.53 and way higher than its 52-week low of $12.71.

Halozyme Therapeutics, Inc.'s Moving Average

Halozyme Therapeutics, Inc.'s value is above its 50-day moving average of $40.97 and way above its 200-day moving average of $31.28.

3. PayPal

21.3% sales growth and 17.95% return on equity

PayPal Holdings, Inc. operates as a technology platform and digital payments company that enables digital and mobile payments on behalf of consumers and merchants worldwide.

PayPal's sales growth this year is expected to be 20.6% and 18.6% for next year.

Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 20.3B for the twelve trailing months.

PayPal's sales growth for the next quarter is 21.3%. The company's growth estimates for the current quarter and the next is 15.1% and 48.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.95%.

Volatility

PayPal's last day, last week, and last month's average volatility was a negative 0.98%, a negative 0.57%, and a positive 0.42%, respectively.

PayPal's last day, last week, and last month's high and low average amplitude percentage was 4.60%, 2.96%, and 2.71%, respectively.

PayPal's Stock Yearly Top and Bottom Value

PayPal's stock is valued at $234.91 at 19:22 EST, under its 52-week high of $244.25 and way higher than its 52-week low of $82.07.

PayPal's Moving Average

PayPal's worth is above its 50-day moving average of $218.47 and way above its 200-day moving average of $196.41.

Previous days news about PayPal

According to Business Insider on Saturday, 2 January, "Companies like PayPal added support for cryptocurrency transactions, and some retail investors turned to digital coins as a safe haven (like gold) during the coronavirus pandemic."

According to Business Insider on Monday, 4 January, "It's an equity-based fund, though some of its holdings, such as Square (NYSE:SQ) and PayPal (NASDAQ:PYPL), are increasingly levered to the crypto trade."

According to Business Insider on Monday, 4 January, "Happy Returns has raised $25 million in venture capital from investors including Upfront Ventures and PayPal Ventures."

According to Bloomberg Quint on Tuesday, 5 January, "Its businesses range from ride-hailing and payments to online shopping and delivery -- a local mashup of Uber Technologies Inc., PayPal Holdings Inc., Amazon.com Inc., and DoorDash Inc. It plans to go public in the U.S. and Indonesia."

According to Bloomberg Quint on Tuesday, 5 January, "Divvy, the financial-technology company that offers corporate cards and expense-management software to small businesses, said it's now valued at $1.6 billion after raising money from investors including PayPal Holdings Inc."

According to Bloomberg Quint on Tuesday, 5 January, "The company will offer as much as $180 in credits for purchases made through PayPal with the $550-a-year consumer Platinum card, and up to $1,700 in credits for virtual personal training with luxury-gym chain Equinox, car rentals with Avis Budget Group Inc., purchases on Home Depot Inc.'s website and spending with other retailers."

According to Bloomberg Quint on Tuesday, 5 January, "Affirm was founded in 2012 by Max Levchin, who also co-founded PayPal Holdings Inc. Levchin is the company's single biggest shareholder, according to the filing. "

4. BancFirst Corporation

7% sales growth and 9.86% return on equity

BancFirst Corporation operates as the bank holding company for BancFirst that provides a range of commercial banking services to retail customers, and small to medium-sized businesses.

BancFirst Corporation's sales growth this year is expected to be 5.2% and a negative 1.7% for next year.

Year-on-year quarterly revenue growth declined by 12.8%, now sitting on 379.33M for the twelve trailing months.

BancFirst Corporation's sales growth for the next quarter is 7%. The company's growth estimates for the present quarter and the next is a negative 32.1% and 42.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.86%.

Volatility

BancFirst Corporation's last day, last week, and last month's average volatility was 1.08%, 0.15%, and 0.36%, respectively.

BancFirst Corporation's last day, last week, and last month's high and low average amplitude percentage was 3.01%, 2.58%, and 3.24%, respectively.

BancFirst Corporation's Stock Yearly Top and Bottom Value

BancFirst Corporation's stock is valued at $58.70 at 19:22 EST, below its 52-week high of $63.96 and way higher than its 52-week low of $26.00.

BancFirst Corporation's Moving Average

BancFirst Corporation's worth is above its 50-day moving average of $56.47 and way above its 200-day moving average of $46.02.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com